Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

iRhythm Technologies, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

SAN FRANCISCO, APRIL 30, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ: IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREDICT, AND PREVENT DISEASE, TODAY REPORTED FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH31, 2026.

IRHYTHM HOLDINGS ANNOUNCES FIRST QUARTER 2026 FINANCIAL RESULTS

SAN FRANCISCO, APRIL 28, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ:IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREVENT, AND PREDICT DISEASE, TODAY ANNOUNCED THE COMPANY WILL BE PARTICIPATING IN THE UPCOMING BANK OF AMERICA SECURITIES 2026 HEALTH CARE CONFERENCE. IRHYTHM'S MANAGEMENT IS SCHEDULED TO PRESENT ON WEDNESDAY, MAY 13, 2026, 9:20 A.M.

IRHYTHM HOLDINGS TO PRESENT AT THE BANK OF AMERICA SECURITIES 2026 HEALTH CARE CONFERENCE

REAL-WORLD DATA PRESENTED AT HRS 2026 ADD TO THE BODY OF EVIDENCE SUPPORTING A SHIFT AWAY FROM SHORT-DURATION HOLTER MONITORING TOWARD UP TO 14 DAYS OF CONTINUOUS, UNINTERRUPTED MONITORING WITH ZIO  AMBULATORY ECG DEVICES TO REDUCE MISSED ARRHYTHMIAS AND PROVIDE A MORE COMPLETE ASSESSMENT OF ARRHYTHMIA BURDEN, INCLUDING IN POST-ABLATION AND PREGNANCY POPULATIONS. 1-2 FINDINGS RAISE IMPORTANT CONSIDERATIONS FOR POST-ABLATION ANTICOAGULATION DECISIONS BASED ON PRIOR STUDIES SUCH AS THE OCEAN TRIAL THAT RELIED ON SHORT-DURATION (2448-HOUR) MONITORING, AS THESE DATA SHOW THIS APPROACH WOULD MISS AF RECURRENCE IN 26% OF PATIENTS.

NEW DATA PRESENTED AT HRS 2026 SHOW SHORT-TERM HOLTER MONITORING MISSES A LARGE PROPORTION OF AF RECURRENCE POST-ABLATION AND CLINICALLY SIGNIFICANT ARRHYTHMIAS IN PREGNANCY

SAN FRANCISCO, APRIL 16, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ:IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREVENT, AND PREDICT DISEASE, TODAY ANNOUNCED THAT IT WILL RELEASE FINANCIAL RESULTS FOR THE FIRST QUARTER 2026 AFTER THE CLOSE OF TRADING ON THURSDAY, APRIL 30, 2026. THE COMPANY'S MANAGEMENT TEAM WILL HOST A CORRESPONDING CONFERENCE CALL BEGINNING AT 1:30 P.M. PT / 4:30 P.M. ET.

IRHYTHM HOLDINGS TO REPORT FIRST QUARTER 2026 FINANCIAL RESULTS ON APRIL 30, 2026

SHAREHOLDERS ARE ENCOURAGED TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS AND OPTIONS AT NO COST OR OBLIGATION. WE WOULD HANDLE ANY MATTER ON A CONTINGENT FEE BASIS, WHEREBY YOU WOULD NOT BE RESPONSIBLE FOR OUT-OF-POCKET PAYMENT OF OUR LEGAL FEES OR EXPENSES.

DID IRHYTHM TECHNOLOGIES, INC. INSIDERS BREACH THEIR FIDUCIARY DUTIES TO SHAREHOLDERS?

NEW YORK, APRIL 9, 2026 /PRNEWSWIRE/ -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS. ACCORDING TO A FEDERAL SECURITIES LAWSUIT, INSIDERS AT IRHYTHM CAUSED THE COMPANY TO MISREPRESENT OR FAIL TO DISCLOSE THAT THE ZIO AT MONITOR WAS A REAL-TIME MONITOR INTENDED FOR HIGH-RISK PATIENTS.

KUEHN LAW ENCOURAGES INVESTORS OF IRHYTHM TECHNOLOGIES, INC. TO CONTACT LAW FIRM

DATA PRESENTED AT ACC.26 DEMONSTRATE A HIGH PREVALENCE OF CLINICALLY ACTIONABLE ARRHYTHMIAS ACROSS CKM PATIENT POPULATIONS USING THE ZIO  AMBULATORY ECG PORTFOLIO. 1,2 CHIEF MEDICAL OFFICER MINTU TURAKHIA, MD, MS, DELIVERED THE 57TH ANNUAL LOUIS F.

DATA PRESENTED AT ACC.26 FURTHER DEMONSTRATE THE BENEFITS OF IRHYTHM'S ZIO AMBULATORY ECG PORTFOLIO ACROSS MULTIPLE PATIENT POPULATIONS AS COMPANY LAUNCHES NEW DIGITAL EDUCATION PLATFORM

SAN FRANCISCO, MARCH 12, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ: IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREDICT, AND PREVENT DISEASE, IS PLEASED TO ANNOUNCE THE APPOINTMENT OF JASON PATTEN TO ITS BOARD OF DIRECTORS, EFFECTIVE MARCH 12, 2026. MR. PATTEN BRINGS DECADES OF STRATEGIC LEADERSHIP IN HEALTHCARE, REINFORCING IRHYTHM'S COMMITMENT TO INNOVATION, OPERATIONAL EXCELLENCE, AND LONG-TERM GROWTH.

IRHYTHM HOLDINGS APPOINTS JASON PATTEN TO ITS BOARD OF DIRECTORS

SAN FRANCISCO, FEB. 19, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ: IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREDICT, AND PREVENT DISEASE, TODAY REPORTED FINANCIAL RESULTS FOR THE THREE MONTHS AND FULL YEAR ENDED DECEMBER 31, 2025. FOURTH QUARTER 2025 FINANCIAL HIGHLIGHTS REVENUE OF $208.9 MILLION, A 27.1% INCREASE COMPARED TO FOURTH QUARTER 2024 GROSS MARGIN OF 70.9%, A 90-BASIS POINT INCREASE COMPARED TO FOURTH QUARTER 2024 NET INCOME OF $5.6 MILLION, A $6.9MILLION IMPROVEMENT COMPARED TO FOURTH QUARTER 2024 AND THE FIRST QUARTER OF POSITIVE GAAP NET INCOME IN COMPANY HISTORY ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN OF $34.3 MILLION AND 16.4%, RESPECTIVELY, A $15.0MILLION AND 470-BASIS POINT IMPROVEMENT, RESPECTIVELY, COMPARED TO FOURTH QUARTER 2024 UNRESTRICTED CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $583.8 MILLION AT DECEMBER 31, 2025, A $18.6 MILLION INCREASE FROM SEPTEMBER 30, 2025 FULL YEAR 2025 FINANCIAL HIGHLIGHTS REVENUE OF $747.1 MILLION, A 26.2% INCREASE COMPARED TO FULL YEAR 2024 GROSS MARGIN OF 70.6%, A 170-BASIS POINT INCREASE COMPARED TO FULL YEAR 2024 NET LOSS OF $44.6 MILLION, A $68.7 MILLION IMPROVEMENT COMPARED TO FULL YEAR 2024 ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN OF $68.9 MILLION AND 9.2%, RESPECTIVELY, A $76.7 MILLION AND 1,050-BASIS POINT IMPROVEMENT, RESPECTIVELY COMPARED TO FULL YEAR 2024 FREE CASH FLOW OF $34.5 MILLION, THE FIRST YEAR OF POSITIVE FREE CASH FLOW IN COMPANY HISTORY RECENT OPERATIONAL HIGHLIGHTS RECORD QUARTERLY REVENUE AND FIFTH CONSECUTIVE QUARTERLY REVENUE ABOVE 20% YEAR-OVER-YEAR GROWTH, DRIVEN BY VOLUME ACROSS OUR US CORE BUSINESS, INNOVATIVE HEALTH CHANNELS, AND INTERNATIONAL MARKETS UPCOMING DATA PRESENTATIONS AT THE AMERICAN COLLEGE OF CARDIOLOGY'S ANNUAL SCIENTIFIC SESSION & EXPO IN NEW ORLEANS, LOUISIANA, FROM MARCH 28  30, 2026 THE FOURTH QUARTER CAPPED A TRANSFORMATIONAL YEAR FOR IRHYTHM, SAID QUENTIN BLACKFORD, PRESIDENT AND C

IRHYTHM HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

SAN FRANCISCO, FEB. 05, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ:IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREVENT, AND PREDICT DISEASE, TODAY ANNOUNCED THAT IT WILL RELEASE FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2025 AFTER THE CLOSE OF TRADING ON THURSDAY, FEBRUARY 19, 2026. THE COMPANY'S MANAGEMENT TEAM WILL HOST A CORRESPONDING CONFERENCE CALL BEGINNING AT 1:30 P.M. PT / 4:30 P.M. ET.

iRhythm Technologies, Inc.

IRTC

Price

Financial Reports

No items found.

Press Releases

iRhythm Technologies, Inc.

IRTC.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

IRTC